Cardio Diagnostics Holdings, Inc.
Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · Chicago, IL
CDIO chart
What traders are saying about $CDIO
Latest postsCardio Diagnostics Holdings, Inc. news
- Cardio Diagnostics Holdings Inc. Estimates – NASDAQ:CDIO
TradingView ·
- Biograph Completes First U.S. Study with Caristo Diagnostics’ AI-Powered Coronary Inflammation Detection, Finding Risk in Over 42% of Asymptomatic Patients
Yahoo Finance ·
- Cardio Diagnostics Warrant (CDIOW) Rises 33.70% to $0.01 as Sub-Penny Warrant Draws Speculative Interest - Gap Fill Strategy
www.dars.gov.et ·
- Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges
Yahoo Finance ·
- Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City
Yahoo Finance ·
- Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026
Yahoo Finance ·
- Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans
Yahoo Finance ·
- Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks
Yahoo Finance ·
- Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection
Yahoo Finance ·
- Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians
Yahoo Finance ·
- Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network
Yahoo Finance ·
- Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI
Yahoo Finance ·
Cardio Diagnostics Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $14,825 | $34,890 | $17,065 | $950 |
| Net income | -$6.5M | -$8.4M | -$8.4M | -$4.7M |
| Diluted EPS | $-3.71 | $-9.35 | $-0.66 | $-1.51 |
| Total assets (year end) | $7.8M | $10.6M | $4.5M | $6.2M |
| Cash and equivalents (year end) | $0 | $0 | $0 | $0 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KFORM 8-K
- 8-KFORM 8-K
- 10-QQUARTERLY REPORT
- DEF 14ADEFINITIVE 14A
- 10-QQUARTERLY REPORT
- 10-KANNUAL REPORT
- 8-KFORM 8-K
- 10-QFORM 10-Q
- 8-KFORM 8-K
- DEF 14ADEFINITIVE 14A
- 10-QFORM 10-Q
- 8-KFORM 8-K
About Cardio Diagnostics Holdings, Inc.
- Ticker
- CDIO (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Chicago, IL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1870144
- Former names
- Mana Capital Acquisition Corp.
Frequently asked questions
What exchange is Cardio Diagnostics Holdings, Inc. listed on?
Cardio Diagnostics Holdings, Inc. trades on the Nasdaq under the ticker symbol CDIO.
What industry is Cardio Diagnostics Holdings, Inc. in?
Cardio Diagnostics Holdings, Inc. is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Cardio Diagnostics Holdings, Inc. headquartered?
Cardio Diagnostics Holdings, Inc.'s business address on file with the SEC is in Chicago, IL.
When does Cardio Diagnostics Holdings, Inc.'s fiscal year end?
Cardio Diagnostics Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Cardio Diagnostics Holdings, Inc. report?
Cardio Diagnostics Holdings, Inc. reported $14,825 in revenue for calendar year 2025, according to its SEC filings.